Author

A. Nardone

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Assay:DNA methylation· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

A. Feiglin· 1 shared A. Feit· 1 shared A. Font-Tello· 1 shared A. Ors· 1 shared C. Biagioni· 1 shared C. Guarducci· 1 shared D. Romagnoli· 1 shared E. Moretti· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Feiglin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Sensitive tumor detection, accurate quantification, and cancer subtype classification using low-pass whole methylome sequencing of plasma DNA

M. Paoli, F. Galardi, A. Nardone, C. Biagioni, D. Romagnoli, S. Di Donato, G. M. Franceschini, L. Livraghi, M. Pestrin, G. Sanna, E. Risi, I. Migliaccio, E. Moretti, L. Malorni, L. Biganzoli, , M. Benelli

This paper introduces METER, a computational tool that enables sensitive tumor detection, accurate quantification, and cancer subtype classification using low-pass whole methylome sequencing of plasma DNA.

bioRxiv · Jun 10, 2024 · PreprintCancer Biology

A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer

A. Nardone, X. Qui, A. Feiglin, X. Fu, S. Spisak, A. Feit, G. Cohen Feit, Y. Xie, A. Font-Tello, C. Guarducci, F. Hermida Prado, S. Syamala, K. Lim, M. Pun, M. Cornwell, , R. Jeselsohn

This study identifies a unique chromatin state in invasive lobular breast cancer (ILC) driven by FOXA1-ER axis, leading to tamoxifen resistance and poor outcomes.

bioRxiv · Mar 29, 2022Cancer Biology